Therefore, we believe that our findings are very important; PROZ may become an important potential target to increase the efficacy of targeted immune combination therapy, which provides an important strategy for solving the current difficulties in the treatment of advanced HCC. The gene discussed is PROZ; the disease is hepatocellular carcinoma.